Nestle Health Science US Holdings, Inc.

Nestle Health Science US Holdings, Inc. is a declared insider at 3 companies; the most frequent names are Aimmune Therapeutics, Inc., Seres Therapeutics, Inc. and Axcella Health Inc. Over a trading history stretching from 26 June 2015 to 18 May 2020, the count stands at 5 filings.

No open-market sale appears; the market trades are 3 purchases worth €119.6M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 1 share grant. So far in 2020, the count stands at 3 purchases and no sales.

The median purchase comes to €24.4M. Of 3 purchases, 1 formed part of a group of insiders buying within 30 days of each other. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.

The record was last updated on 21 May 2020 with an open-market purchase (€8.4M) in Axcella Health Inc. Typically, a trade is published a median of 3 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.